Ki-67 expression as a prognostic factor in diffuse large B-cell lymphoma patients treated with rituximab plus CHOP. [electronic resource]
Producer: 20100817Description: 149-57 p. digitalISSN:- 1600-0609
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cell Proliferation -- drug effects
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Humans
- Ki-67 Antigen -- analysis
- Lymphoma, Large B-Cell, Diffuse -- diagnosis
- Middle Aged
- Prednisone -- administration & dosage
- Prognosis
- Recurrence
- Rituximab
- Survival Analysis
- Vincristine -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.